The Annual General Meeting of Lifecare has elected Morten Foros Krohnstad, Lifecare Deputy Chairman, as the new Chairman of Lifecare Board of Directors.
Read more
News archive
The Annual General Meeting of Lifecare has elected Morten Foros Krohnstad, Lifecare Deputy Chairman, as the new Chairman of Lifecare Board of Directors.
Read more
Lifecare is pleased to announce Kine Hereidas its new Controller and head of Investor Relations.
Read more
Det er mulig å delta digitalt på Lifecares Generalforsamling 2021 (7. mai kl 10:00). Vi benytter en styre- og generalforsamlingsportal fra Orgbrain for digital gjennomføring. For å sikre at generalforsamlingen blir gjennomført på en mest mulig smidig måte, inviterer Lifecare og Orgbrain til et webinar der det vil bli gitt en innføring i hvordan du som aksjonær […]
Read more
Lifecare AS will hold a General Meeting on 7 May 2021 at 10:00.
Read more
Lifecare is today publishing its annual report with accounts for 2020.
Read more
4. April 2021, Bergen - Digital Diagnostics AG’s (Digid) management has filed for bankruptcy at the district court of Mainz. The filing was delivered without any prior information to or discussion with the Digid Supervisory board.
Read more
25 March 2021, Bergen – Today, Lifecare announces that The European Patent Office has issued its intent to grant Lifecare a new patent, expanding Lifecare’s patent protection in time and scope. Lifecare has reviewed the examining division’s comments to the patent application and concludes that the suggested cosmetic changes are acceptable. On this base, Lifecare […]
Read more
March 19th, 2021,Bergen – Lifecare’s partner, Digital Diagnostics AG (Digid), has developed a novel 5-minute antigen rapid virus detection test. The Cantisense test method is based on proteins binding onto the virus antigen, which leads to electronically measurable changes. The method is highly sophisticated and advanced compared to already existing virus detection test methods: […]
Read more
Lifecare has received regulatory approval for thefirst-in-human Sencell Clinical Study Protocol from the German FederalInstitute for Drugs and Medical Devices (BfArM). With this final remaining approval, Lifecare has reached its goal to have clinical pilot trial permission as planned in Q1 2021. “With this regulatory approval, Lifecare has achieved amajor milestone in the development […]
Read more
Lifecare preliminary concludes a net profit of NOK 1.46M in Q4 2020, vs. NOK -1.2M in Q3 2020 and NOK -2,16M in 1H 2020. Lifecare expect a net profit of NOK -2.2M for the year 2020, which is an improvement from the net profit for the year 2019 ending at NOK -6.5M. The Tax Incentive […]
Read more